Xiaorong Zhong

机构：North Sichuan Medical University, Sichuan University, Zhengzhou University, Beijing VDJBio (China), West China Hospital of Sichuan University, Sichuan Cancer Hospital, Shaanxi University of Science and Technology · ORCID：0000-0003-1812-7213

发表论文 139 篇 · 总被引 2000 次 · h-index 24

代表论文

• HER2-targeted therapies in cancer: a systematic review (2024 · Biomarker Research · 被引 130)
• Pyrotinib and chrysin synergistically potentiate autophagy in HER2-positive breast cancer (2023 · Signal Transduction and Targeted Therapy · 被引 38)
• HER2‐low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis (2023 · Cancer · 被引 24)
• A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis (2023 · BMC Geriatrics · 被引 22)
• Efficacy and safety of tucidinostat in patients with advanced hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer: real-world insights (2023 · Annals of Translational Medicine · 被引 10)
• Integrating ultrasound radiomics and clinicopathological features for machine learning-based survival prediction in patients with nonmetastatic triple-negative breast cancer (2025 · BMC Cancer · 被引 9)